Table 3. Demographic characteristics and anesthetic management of patients who underwent McKeown MIE and Ivor Lewis MIE.
| Baseline characteristics | Operation performed | P value | |
|---|---|---|---|
| McKeown MIE (n=33) | Ivor-Lewis MIE (n=20) | ||
| Pathology | 0.056 | ||
| Squamous cell carcinoma | 32 (97%) | 17 (85%) | |
| Adenocarcinoma | 0 (0%) | 3 (15%) | |
| Neuroendocrine carcinoma | 1 (3%) | 0 (0%) | |
| Staging | 0.709 | ||
| ASA classification | 0.412 | ||
| Surgical time (min) | 529.5±87.8 | 474.3±52.3 | 0.016 |
| Intraoperative fluid management | |||
| Crystalloid (mL) | 2,731.5±979.8 | 2,000±801 | 0.008 |
| Voluven 500 mL infusion | 9 (27.3%) | 5 (25%) | 0.43 |
| Albumin 100 mL infusion | 14 (42.4%) | 10 (50%) | 0.336 |
| Blood transfusion | 3 (9.1%) | 5 (25%) | 0.111 |
| Extubate in operating room | 23 (69.7%) | 13 (65%) | 0.429 |
Data were expressed as N (%) and mean ± SD. MIE, minimal invasive esophagectomy; PCA, patient-controlled analgesia.